Medlab Middle East puts laboratories under the microscope for a greener healthcare system
The Lab Sustainability Conference at the Medlab Middle East Congress explored how laboratories can adopt eco-friendly practices, optimise resources and balance sustainability with high quality patient care
Speakers at the conference today discussed how climate change is leading to a range of health conditions including allergic diseases, autoimmune diseases and cancers
Elsewhere today at Medlab Middle East, experts discussed AI in clinical chemistry and provided updates on the Emirates Genome Programme
Dubai, United Arab Emirates: As the healthcare industry intensifies its focus on environmental responsibility, the Lab Sustainability Conference was held today at Medlab Middle East, addressing the crucial role of clinical laboratories in building a more sustainable healthcare system.
With rising global temperatures and increasing environmental challenges, the impact on healthcare and laboratory professionals is expected to grow significantly. The conference explored how laboratories can adopt eco-friendly practices, optimise resource use, and balance ecological, social, and economic considerations while maintaining high-quality patient care.
One of the key discussions delved into the Doughnut Economy model and its relevance to laboratory sustainability. The economic framework created by economist Kate Raworth, aims to achieve sustainable growth without exceeding ecological limits. The model is shaped like a doughnut, where the inner ring represents essential needs such as food, healthcare, and education, and the outer ring symbolises ecological factors such as climate stability and biodiversity. The goal is to operate within this safe zone, ensuring economic and social progress without exceeding ecological limits.
Opening the Lab Sustainability conference Dr. Rana Nabulsi, Chair, Lab Quality and Safety Committee, DLMP, Dubai Health, said: 'Medical laboratories and pathology departments around the world consume five to ten times more energy and five times more water than standard office spaces. Additionally, these departments are responsible for discarding 5.5 million tonnes of plastic into the oceans, leading to significant public health impacts due to microplastics. There are also considerable financial costs associated with energy consumption and waste output. Today, our esteemed speakers will explore various aspects of climate change, its effects on public health, and the solutions that laboratories can implement to help mitigate these risks.'
Following the opening address from Dr. Nabulsi, Dr. Ali Al-Hemoud, a member of the Technical Advisory Group on Global Air Pollution for the World Health Organization (WHO) and a health research scientist at the Kuwait Institute for Scientific Research, led a fascinating session titled 'Immune-Mediated Diseases Associated with the Effects of Air Pollution.' The session focused on the exposome, which refers to the total collection of environmental exposures a person encounters throughout their life.
Al-Hemoud said: 'Climate change is causing environmental hazards such as thunder storms, sand and dust storms and air pollution. Our research examines how these environmental hazards are affecting the exposome. These exposome factors, specifically air pollution, greenhouse gases, pollen and biodiversity will all detrimentally affect humans over their lifetimes. These factors can cause immune degradation, leading to immune-mediated diseases including allergic diseases, autoimmune diseases and cancers.'
Elsewhere today at the Medlab Middle East Congress, the Clinical Chemistry track explored the role of artificial intelligence, automation and digital transformation in shaping value-based laboratory diagnostics, while the Molecular Diagnostics conference focused on cancer genomics and the genomics of rare diseases in the Middle East region.
During the Molecular Diagnostics conference today, Dr. Mohamed Alameri, Head of Studies and Special Projects, Department of Health, Abu Dhabi provided the latest updates on the Emirates genome programme including its achievements, implications and future directions.
The Medlab Middle East Congress, the world's only multi-disciplinary congress, concludes tomorrow with the Lab Quality, Blood Transfusion and Cellular Therapy and Immunology tracks. Offering 12 live, in-person tracks, the congress provides exceptional education as well as management solutions to assist medical lab professionals advance their skills and improve overall service.
Medlab Middle East is the region's largest medical laboratory exhibition and conference, The previous edition of Medlab Middle East generated an estimated business value of USD670 million (AED2.46 billion), fueling medical laboratory growth across the Middle East and beyond. The 24th edition of the event concludes tomorrow at the Dubai World Trade Centre.
-Ends-
About Medlab Middle East
As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in advancing the value of laboratory medicine worldwide, shaping the future of diagnostics by providing an international platform for laboratory industry leaders, including manufacturers, dealers and distributors to share best practice, showcase innovations, collaborate and network.
Medlab Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Now in its 24th year, this annual medical laboratory meeting brings together exhibitors and attendees from over 180 countries.
Medlab Middle East will take place from 3 – 6 February 2025 at the Dubai World Trade Centre, Dubai, UAE. A digital event will occur from 4 December – 20 February 2025.
Website: medlabme.com
Facebook: facebook.com/medlabseries
Twitter: @MedlabSeries #myMedlab
Instagram: @medlab.series
LinkedIn: Medlab Middle East
For more information, please get in touch with Shamal Communications:
Media Contact
CATHERINE ALLTOFT
ACCOUNT DIRECTOR
E-mail : catherine.alltoft@shamalcomms.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
a day ago
- Zawya
PolyU startups showcase innovation and entrepreneurial achievements at London Tech Week 2025
HONG KONG SAR - Media OutReach Newswire - 12 June 2025 - The Hong Kong Polytechnic University (PolyU) took part in the world-renowned London Tech Week 2025 held from 9 to 11 June in London, UK, as the only participating university from Hong Kong. Four PolyU startups showcased their ground-breaking innovations in artificial intelligence (AI), advanced manufacturing technologies and healthcare solutions. The event attracted business leaders, industry experts and investors from around the world, providing the PolyU startups with valuable opportunities to explore potential collaborations and establish partnerships. PolyU is committed to translating cutting-edge research into impactful solutions that address real-world challenges. Below are introductions to the four PolyU startups. PolyU Startup Founder(s) Introduction Advantage Data Vision Limited Prof. Lawrence Wing Chi CHAN Associate Professor, Department of Health Technology and Informatics; and Director, Advantage Data Vision Limited The startup has leveraged massive real‑world, multi‑omics datasets and patented AI algorithms to create a cloud‑based platform that accurately predicts patients' response to cancer immunotherapy. The deep‑learning engine guides clinicians, optimises hospital resources, reduces adverse events and accelerates pharmaceutical trials through precise patient stratification and risk assessment, delivering tangible value worldwide. Light-weight Technologies Limited Prof. Jianguo LIN Chair Professor of Materials Technologies, Department of Industrial and Systems Engineering; and Co-founder and Chairman, Light-weight Technologies Limited Dr Qingsong WENG Research Associate, Department of Industrial and Systems Engineering; and Co-founder and Chief Executive Officer, Light-weight Technologies Limited The startup uses their globally unique light alloy manufacturing technologies, such as advanced hot stamping and extrusion techniques, with its self-developed smart industrial software and advanced simulation platform to produce ultra-thin, ultra-wide light alloy profiles and complex curved profiles that are unattainable with existing manufacturing processes. The startup provides high-strength, lightweight, cost-effective, and sustainable solutions that enable energy saving and emission reduction for the automotive, aerospace, railway, marine, and other engineering sectors, gaining wide recognition from leading global OEMs. UbiquiTech Innovations Limited Prof. Jiannong CAO Dean, Graduate School; Otto Poon Charitable Foundation Professor in Data Science; Chair Professor of Distributed and Mobile Computing; Director, Research Institute for Artificial Intelligence of Things; Director, University Research Facility in Big Data Analytics; and Co-founder and Chief Scientist, UbiquiTech Innovations Limited Dr Zhixuan LIANG PolyU GBA Postdoctoral Fellow; and Chief Executive Officer, UbiquiTech Innovations Limited The startup is committed to the intersection of robotics, AI and smart city solutions, with a view to developing cutting-edge autonomous robots designed to address complex challenges in modern urban and industrial environments. viAct Mr Gary Chun-kui NG Co-founder and Chief Executive Officer, viAct Mr Hugo CHEUK Co-founder and Chief Operating Officer, viAct viAct is a pioneer in AI monitoring technology dedicated to enhancing safety and efficiency in heavy industries such as construction, oil and gas, and manufacturing. The startup made it onto Forbes Asia 100 to Watch list in 2022. Its leading, globally deployed technology "Scenario-based Vision Intelligence", was showcased at renowned international events such as the World Economic Forum. At the event's panel discussion themed "Creating the Future from Campus: Why are University Spinouts so Important for Innovation?", Prof. Christopher CHAO, PolyU Vice President (Research and Innovation), shared his insights into knowledge transfer, the nurturing of university spinouts, and the support and resources available to PolyU startups. Prof. Chao remarked, "Supported by PolyU's signature startup ecosystem, PolyVentures, our startups are spearheading translational innovations that generate long-lasting global societal impact. Our ecosystem not only provides invaluable development opportunities but also fosters the international growth of our entrepreneurs. I am delighted to see PolyU startups shine at London Tech Week, inspiring global audiences with their creativity and determination to make a difference." This year, the London Tech Week attracted over 45,000 participants from more than 90 countries, including startups, technology giants, investors and innovators. The event provided a platform for startups to engage in person with venture capitalists, corporate investors and angel investors; promote their solutions on dedicated stages; connect with industry leaders at the forefront of innovation; and gain valuable insights from successful entrepreneurs who have expanded globally. For more information, please visit the event website. Hashtag: #PolyU The issuer is solely responsible for the content of this announcement. PolyU
Gulf Today
2 days ago
- Gulf Today
UAE performs first robotic surgery with HIPEC
Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) to treat a rare appendiceal tumour, in a medical milestone that reinforces Abu Dhabi's position as a global destination for innovative healthcare. The complex procedure, performed on a 48-year-old patient, involved the removal of multiple internal organs to prevent the spread of the tumour in her abdomen. This groundbreaking procedure was led by Dr Yasir Akmal, Staff Physician in the Digestive Disease Institute at Cleveland Clinic Abu Dhabi and an American Fellowship-trained surgical oncologist, and a multi-disciplinary team. Appendiceal tumours account for less than 1 per cent of malignancies worldwide and are found in approximately 1.4 per cent of patients who undergo an appendectomy. The patient initially presented symptoms resembling appendicitis, leading to the removal of her appendix. However, during the procedure, her surgeon discovered gelatinous deposits, a jelly-like substance, in the abdominal cavity. A subsequent pathology report confirmed the presence of a rare low-grade mucinous neoplasm, a tumour that, if untreated, could spread throughout the abdomen and result in a condition known as pseudomyxoma peritonei or 'jelly belly.' Dr Georges-Pascal Haber, Chief Executive Officer of Cleveland Clinic Abu Dhabi, said, 'We are pushing the boundaries of robotic surgery and are proud to have used such an advanced technology for a complex procedure like Paola's. Cleveland Clinic Abu Dhabi is a leader in surgical innovation, continuously refining minimally invasive techniques to improve outcomes and enhance quality of life.' Following the tumour removal, HIPEC treatment (Hyperthermic Intraperitoneal Chemotherapy) was administered- a technique where heated chemotherapy (42 degrees Celsius) is circulated within the abdominal cavity for 90 minutes to eliminate any residual cancer cells. Highlighting both the preventive and curative nature of the surgery, Dr Akmal said that the patient's condition was diagnosed at an advanced but treatable stage, and thanks to the timely intervention of the multidisciplinary team, supported by specialised AI-driven diagnostic tools, the team was able to navigate the process of eliminating the cancer cells in her body with precision. WAM
The National
3 days ago
- The National
UK expands visas for AI talent
The UK government is aiming to more than double the number of science fellowships it awards as part of a drive to boost the UK's AI infrastructure, its technology secretary announced on Tuesday. Peter Kyle said the government would not shy away from 'risk' when it came to developing AI infrastructure in the UK, but that it needed overseas talent to do so, as well as training new generations at home. 'Our tech success wouldn't have been possible without brilliant people choosing time and time again to call Britain home. In an ever in an ever more competitive world, we simply can't afford to lose that status,' Mr Kyle said. 'So we will introduce a new scheme to attract the brightest and the best brains to Britain,' he said, speaking at London Tech Week conference. Mr Kyle said the UK government would 'double' the number of places available in its Encode: AI science fellowship, which embeds AI researchers into UK labs. The next cohort is expected to start in Autumn. He also announced the launch of the Turing AI 'Global' Fellowship, to attract five AI experts to the UK. This is in addition to existing Turing AI Fellowships which have been available since 2019. Global fellows will receive packages to relocate to the UK and build a team of experts to conduct 'frontier' AI research that contributes to the UK's infrastructure. It comes as Prime Minister Keir Starmer announced a 'national skills drive' worth £187 million ($239 million) to give 'over a million students' the chance to start careers in AI on Monday. Mr Starmer also pledged a £1 billion investment in AI compute – the microchips, processing units and cabling that make AI systems function – and announced a new government AI assistant called 'Extract' to help process planning applications. Mr Kyle said the UK had been overburdened by a ' regulatory regime that was stuck in the past', and that the new government was prepared to take 'risks' to use AI and technology to stimulate jobs and cut costs. He spoke of British businesses who were seeking better opportunities overseas. 'When countries become preoccupied with avoiding risk, they risk resisting innovation,' he said. 'Too often Britain has felt like a country where people resist innovation.' Mr Kyle also said that a centre focused on accelerating the adoption of AI will be established at London's Imperial College, in partnership with the UK government and the World Economic Forum. The UK government will also work on creating OpenBind, 'world's largest database' analysing how drugs interact with proteins. Mr Kyle said the project 'could cut the cost of developing new treatments by up to £100 billion'.
